Healthcare provider profile · identity verified

Manuel Silva

Nurse Practitioner · HALLANDALE BEACH, FL · NPI 1225455694

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	732	283
Metoprolol Succinate	Metoprolol Succinate	321	113
Losartan Potassium	Losartan Potassium	314	124
Amlodipine Besylate	Amlodipine Besylate	299	123
Gabapentin	Gabapentin	249	104
Lisinopril	Lisinopril	233	92
Vitamin D2	Ergocalciferol (Vitamin D2)	227	105
Metformin Hcl	Metformin Hcl	209	88
Meloxicam	Meloxicam	176	103
Rosuvastatin Calcium	Rosuvastatin Calcium	171	71
Tamsulosin Hcl	Tamsulosin Hcl	170	66
Glipizide	Glipizide	169	58
Levothyroxine Sodium	Levothyroxine Sodium	158	51
Omeprazole	Omeprazole	150	61
Pantoprazole Sodium	Pantoprazole Sodium	150	63
Albuterol Sulfate Hfa	Albuterol Sulfate	145	43
Nifedipine Er	Nifedipine	139	51
Diclofenac Sodium	Diclofenac Sodium	113	44
Tizanidine Hcl	Tizanidine Hcl	104	66
Methocarbamol	Methocarbamol	101	70
Hydrochlorothiazide	Hydrochlorothiazide	96	45
Naproxen	Naproxen	96	63
Alendronate Sodium	Alendronate Sodium	93	43
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	91	21
Memantine Hcl	Memantine Hcl	82	31
Clopidogrel	Clopidogrel Bisulfate	81	33
Carvedilol	Carvedilol	78	30
Clonidine Hcl	Clonidine Hcl	71	42
Ibuprofen	Ibuprofen	66	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	24
Furosemide	Furosemide	65	29
Buspirone Hcl	Buspirone Hcl	62	25
Novolog Flexpen	Insulin Aspart	61	12
Eliquis	Apixaban	60	23
Trazodone Hcl	Trazodone Hcl	59	27
Montelukast Sodium	Montelukast Sodium	58	21
Simvastatin	Simvastatin	55	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	32
Sertraline Hcl	Sertraline Hcl	53	24
Triamcinolone Acetonide	Triamcinolone Acetonide	53	30
Doxycycline Hyclate	Doxycycline Hyclate	51	43
Pioglitazone Hcl	Pioglitazone Hcl	51	20
Meclizine Hcl	Meclizine Hcl	50	27
Metoprolol Tartrate	Metoprolol Tartrate	49	22
Valsartan	Valsartan	49	15
Ketoconazole	Ketoconazole	47	24
Methylprednisolone	Methylprednisolone	47	41
Dicyclomine Hcl	Dicyclomine Hcl	46	27
Escitalopram Oxalate	Escitalopram Oxalate	46	21
Famotidine	Famotidine	45	23
Azithromycin	Azithromycin	43	41
Ammonium Lactate	Ammonium Lactate	42	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	40
Prednisone	Prednisone	40	30
Donepezil Hcl	Donepezil Hcl	37	19
Latanoprost	Latanoprost	37	12
Ezetimibe	Ezetimibe	35	16
Hydroxyzine Hcl	Hydroxyzine Hcl	34	21
Lactulose	Lactulose	34	13
Sildenafil Citrate	Sildenafil Citrate	34	13
Allopurinol	Allopurinol	33	15
Folic Acid	Folic Acid	33	14
Hydrocortisone	Hydrocortisone	33	13
Mirtazapine	Mirtazapine	33	16
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	32	13
Fluticasone Propionate	Fluticasone Propionate	31	14
Irbesartan	Irbesartan	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	11
Ozempic	Semaglutide	31	suppressed
Baclofen	Baclofen	30	13
Duloxetine Hcl	Duloxetine Hcl	30	13
Entresto	Sacubitril/Valsartan	30	suppressed
Amoxicillin	Amoxicillin	29	28
Atenolol	Atenolol	28	11
Ciclopirox	Ciclopirox Olamine	27	15
Loperamide	Loperamide Hcl	27	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	13
Citalopram Hbr	Citalopram Hydrobromide	25	13
Glipizide Er	Glipizide	25	11
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Mometasone Furoate	Mometasone Furoate	23	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	21	17
Metformin Hcl Er	Metformin Hcl	21	11
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	18
Fenofibrate	Fenofibrate,micronized	19	suppressed
Finasteride	Finasteride	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Lidocaine	Lidocaine	18	suppressed
Desloratadine	Desloratadine	17	12
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	15
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Jardiance	Empagliflozin	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Ergotamine-Caffeine	Ergotamine Tartrate/Caffeine	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Mupirocin	Mupirocin	14	13
Potassium Chloride	Potassium Chloride	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Ssd	Silver Sulfadiazine	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error